Mobile

RECORD 2 Study: REgulation of Coagulation in ORthopedic Surgery to prevent DVT and PE, controlled, Double-Blind, Randomized Study of BAY59-7939 in the Extended Prevention of VTE in Patients Undergoing...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-004691-20

RECORD 2 Study: REgulation of Coagulation in ORthopedic Surgery to prevent DVT and PE, controlled, Double-Blind, Randomized Study of BAY59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The objective of this trial is to compare the efficacy and safety of VTE prophylaxis with BAY 59-7939 10 mg once daily administered for 5 weeks to enoxaparin 40 mg once daily (qd) administered for 10-14 days followed by placebo in men and women aged 18 years or above undergoing elective total hip replacement.

Critère d'inclusion

  • Prevention of venous thromboembolism

Liens